Granulocyte-colony stimulating factor (G-CSF)-primed, delayed marrow harvests as a source of hematopoietic stem and progenitor cells for allogeneic transplantation

Leukemia and Lymphoma

Volumn 35, Issue 3-4, 1999, Pages 303-309

  Phillips, G L ^a   Davey, D D ^b   Hale, G A ^a   Marshall, K W ^a   Munn, R K ^a   Nath, R ^a   Reece, D E ^a   Van Zant, G ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; G CSF; Marrow harvest

Indexed keywords

ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LARGE CELL LYMPHOMA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 0032707789     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145734     Document Type: Article

References (24)

1. Korbling M, Champlin R. (1996) Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells 14:185-95.
2. Janssen WE. (1993) Peripheral blood and bone marrow hematopoietic stem cells: are they the same? Semin Oncol 20:19-27.
3. Fielding AK, Watts MJ, Goldstone AH. (1994) Peripheral blood progenitor cells versus bone marrow. J Hematother 3:299-304.
4. Weisdorf DJ, Verfaule CM, Miller WJ, et al. (1997) Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial. Am J Hematol 54: 202-8.
5. Janssen WE, Smilee RC, Elfenbein GJ. (1995) A prospective randomized trial comparing blood- and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy. J Hematother 4:139-40.
6. Damiani D, Fanin R, Silvestri F, et al. (1997) Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 90:36-42.
7. Weisdorf D, Miller J, Verfaille C, et al. (1994) Cytokine-primed bone marrow stem cells vs peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs G-CSF. Biol Blood Marrow Transplant 3(4):217-23.
8. Dicke KA, Hood DL, Arneson M, et al. (1997) Effects of short-term in vivo administration of G-CSF on bone marrow prior to harvesting. Exp Hematol 25(1):34-8.
9. Lowenthal RM, Sullivan SA, Parker N, Marsden KA. (1996) G-CSF-primed bone marrow cells for autologous transplantation. Lancet 347(9008):1125.
10. Hansen PB, Johnsen HE, Ralfkiaer E, et al. (1995) Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF, or rhIL-3 before marrow harvest expands myelpoiesis but does not improve engraftment capability. Bone Marrow Transplant 16(3):373-379.
11. Isola LM, Scigliano E, Skerrett D, et al. (1997) A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 20(2):1033-37.
12. Mavroudis DA, Read EJ, Molldrem J, et al. (1998) T-cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia. Bone Marrow Transplant 21(5):431-440.
13. Emerson SG. (1995) The potential tor clinical ex vivo hematopoiesis. Ann NY Acad Sci 70:99-104.
14. Larochelle A, Vormoor J, Hanenberg H, et al. (1996) Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat Med 2(12):1329-37.
15. Bungart B, Loeffler M, Goris H, et al. (1990) Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 76(2):174-79.
16. de Haan G, Dontje B, Engel C, et al. (1995) The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. Blood 86(8):2986-92.
17. Bodine DM, Seidel NE, Orlic D. (1996) Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88(1):89-97.
18. Dunbar CE, Seidel NE, Doren S, et al. (1996) Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 93(21):11871-6.
19. Beelen DW, Ottinger HD, Elmaagacli A, et al. (1997) Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 90(12):4725-35.
20. Anderlini P, Przepiorka D, Champlin R, Korbling M. (1996) Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88(8):2819-25.
21. Sosman JA, Stiff PJ, Bayer RA, et al. (1995) A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Bone Marrow Transplant 16(5):655-61.
22. Vliagoftis H; Worohec AS; Metcalfe DD. (1997) The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol 100(4):435-40.
23. Brashem-Stein C; Flowers DA; Bernstein ID (1996) Regulation of colony forming cell generation by flt-3 ligand. Br J Haematol 94(1):17-22.
24. Storek J, Gooley T, Siadek M, et al. (1997) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chrome graft-versus-host disease. Blood 90(12):4705-09.